Research graph
References from Discovery HIV Vaccine Trial Implementation in Malawi: Insights from a Stakeholder Engagement Meeting. Local targets link to admitted publications; unresolved targets remain external evidence.
Have the explosive HIV epidemics in sub-Saharan Africa been driven by higher community viral load?.
10.1097/qad.0b013e32835cb927 · 2013 · External reference
Understanding the gender disparity in HIV infection across countries in sub-Saharan Africa: evidence from the Demographic and Health Surveys.
10.1111/j.1467-9566.2010.01304.x · 2011 · External reference
Sustained Viral Suppression in HIV-Infected Patients Receiving Antiretroviral Therapy.
10.1001/jama.2012.5927 · 2012 · External reference
Impact of age on CD4 recovery and viral suppression over time among adults living with HIV who initiated antiretroviral therapy in the African Cohort Study.
10.1186/s12981-020-00323-x · 2020 · External reference
Time to Viral Rebound After Interruption of Modern Antiretroviral Therapies.
10.1093/cid/ciab541 · 2022 · External reference
Non-clinical safety of GRAd vector-based COVID-19 and HIV vaccines supports a platform regulatory approach.
10.1101/2025.11.24.689034 · External reference
Clinical Research Trial Listing (HIV) (NCT06617091).
External reference
Molecular Epidemiology of HIV-1 in African Countries: A Comprehensive Overview.
10.3390/pathogens9121072 · 2020 · External reference
Subnational HIV incidence trends in Malawi: large, heterogeneous declines across space.
10.1101/2023.02.02.23285334 · External reference
Health Research Policy and Systems|Springer Nature Link.
10.1186/1478-4505-7-s1-s14 · External reference
Medicines Regulation in Africa: Current State and Opportunities.
10.1007/s40290-017-0210-x · 2017 · External reference
WHO|Regional Office for Africa.
External reference
Vaccine-induced HIV seropositivity/reactivity in noninfected HIV vaccine recipients.
10.1001/jama.2010.926 · 2010 · External reference
Ethical issues in HIV vaccine trials in South Africa.
2000 · External reference
Linking research to global health equity: the contribution of product development partnerships to access to medicines and research capacity building.
10.2105/ajph.2013.301341 · 2013 · External reference
